Berkeley Heights, NJ, June 7, 2002
-Genta Incorporated (Nasdaq: GNTA) announced today that the company
has been invited to make several presentations at the BIO 2002 16th
Annual International Biotechnology Convention & Exhibition in
Toronto.
The first presentation will be made by Dr. Raymond P. Warrell,
Jr., Genta's Chairman and CEO, and will occur on Tuesday, June 11,
2002 at 4:30 pm EST. A live audio webcast will be available
during the presentation and can be accessed via the following link:
http://events01.activate.net/thomson/bio/2988/registration/default.asp
.
Listeners should go to the site at least 15 minutes prior to the
event to register. To save time on the day of the presentation,
pre-registration is available now. Replays will be available
two hours after completion of the presentation and archived for 30
days.
In addition to Dr. Warrell's Corporate presentation, Thomas G.
Burger, Vice President of Corporate Development, will present a
talk entitled "The Little Fish Swims Downstream: The Trend in
Early-Stage Partnering Deals Toward Greater Late-Stage
Participation." Mr. Burger's presentation will occur on Wednesday,
June 12, 2002, at 4:00 pm EST
Genta Incorporated
is a biopharmaceutical company with a diversified product portfolio
that is focused on anticancer therapy. The Company's research
platform is anchored by DNA Medicines, particularly applications of
antisense and decoy aptamers. GenasenseTM, the Company"s lead
compound, is currently in Phase 3 trials for melanoma, multiple
myeloma, chronic lymphocytic leukemia, and non-small cell lung
cancer. The drug is also being studied in Phase 2 trials for
leukemia, lymphoma, and prostate and small cell lung cancers.
Genta's drug pipeline also comprises a portfolio of small
molecules, including Gallium Products for treatment of cancer and
accelerated bone loss, and Androgenics Compounds for treatment of
prostate cancer. Genta aims to become a direct marketer of
its pharmaceutical products in North America. For more
information about Genta, please visit our website at:
http://www.genta.com/
.